STOCK TITAN

Dimensional Fund Advisors (ENOV) discloses 4.9% Enovis Corp stake in 13G/A

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Dimensional Fund Advisors LP filed an amended Schedule 13G reporting a passive ownership stake in Enovis Corp common stock. As of 12/31/2025, Dimensional is deemed to beneficially own 2,781,936 shares, representing 4.9 % of Enovis’s common stock. It reports sole voting power over 2,724,038 shares and sole dispositive power over 2,781,936 shares, with no shared voting or dispositive power.

The shares are actually owned by various funds and accounts it advises (the “Funds”), and Dimensional disclaims beneficial ownership, stating that all securities are owned by the Funds. Dimensional also certifies that the holdings were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Enovis.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Dimensional Fund Advisors LP
Signature:Selwyn Notelovitz
Name/Title:Global Chief Compliance Officer
Date:01/21/2026
Enovis Corp

NYSE:ENOV

ENOV Rankings

ENOV Latest News

ENOV Latest SEC Filings

ENOV Stock Data

1.27B
56.23M
1.57%
121.34%
12.07%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WILMINGTON